Activity transition—mechanization and effect on physical activities
Limitations of the INTERHEART and INTERSTROKE Studies
Prevention of CVD
National prevention guidelines
- Piepoli M.F.
- Hoes A.W.
- Agewall S.
- et al.
The Canadian Cardiovascular Society guidelines
The AHA/ACC guidelines
The ESC guidelines
- Piepoli M.F.
- Hoes A.W.
- Agewall S.
- et al.
- Piepoli M.F.
- Hoes A.W.
- Agewall S.
- et al.
Current Status on Risk Factors Control
Drug Use in Secondary Prevention of CVD
Lifestyle Modifications in Secondary Prevention
Association between micronutrients and CVD and mortality
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet. 2016; 388: 1459-1544
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet. 2012; 380: 2197-2223
- Global burden of cardiovascular diseases.Circulation. 2001; 104: 2855-2864
- Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies.Circulation. 2001; 104: 2855-2864
- Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991.BMJ. 1998; 316: 1047
- Contrasting coronary heart disease risk profiles between urban and rural Indians: the PURE pilot study.J Am Coll Cardiol. 2002; 39: 41B
- Emerging epidemic of cardiovascular disease in developing countries.Circulation. 1998; 97: 596-601
- Socioeconomic status and obesity in adult populations of developing countries: a review.Bull World Health Organ. 2004; 82: 940-946
- The economics of obesity: dietary energy density and energy cost.Am J Clin Nutr. 2005; 82: 265S-273S
- Rapid income growth adversely affect diet quality in China – particularly for the poor!.Soc Sci Med. 2004; 59: 1505-1515
- Framingham contribution to cardiovascular disease.Heart Views. 2016; 17: 78-81
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet. 2016; 388: 1603-1658
- Mortality by cause for eight regions of the world: Global Burden of Disease Study.Lancet. 1997; 349: 1269-1276
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.Lancet. 2004; 364: 937-952
- Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.Lancet. 2016; 388: 761-775
- Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.Lancet. 2020; 395: 795-808
- Challenges and opportunities for cardiovascular disease prevention.Am J Med. 2011; 124: 95-102
- 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2019; 140: e596-616
- 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult.Can J Cardiol. 2016; 32: 1263-1282
- Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update.CMAJ. 2018; 190: E1192-E1206
- Availability and affordability of cardiovascular disease medicine and their effect on use in high-income, middle-income and low income countries: an analysis of the PURE study data.Lancet. 2016; 387: 61-69
- Prevention of cardiovascular disease. Guidelines for assessment and management of cardiovascular risk.World Health Organization, Geneva2007
- 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention and rehabilitation (EACPR).Eur Heart J. 2016; 37: 2315-2381
- Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies.PLoS One. 2014; 9e84238
- Adherence to medication.N Engl J Med. 2005; 353: 487-497
- Medication adherence: its importance in cardiovascular outcomes.Circulation. 2009; 119: 3028-3035
- Cardiovascular risk and events in 17 low-, middle- and high-income countries.N Engl J Med. 2014; 371: 818-827
- Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income and low-income countries (the PURE Study): a prospective epidemiological survey.Lancet. 2011; 378: 1231-1243
- Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study.JAMA. 2013; 309: 1613-1621
- Availability, affordability, and consumption of fruits and vegetables in 18 countries across income levels: findings from the Prospective Urban Rural Epidemiology (PURE) study.Lancet Global Health. 2016; 4: e695-703
- Tobacco: global and community solutions.Evidence-Based Cardiology. 2nd Ed. BMJ Books, London2003: 103-113
- Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study.Lancet. 2006; 368: 647-658
- The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK.Lancet. 2013; 381: 133-141
- The 21st century hazards of smoking and benefits of cessation in the United States.N Engl J Med. 2013; 368: 341-350
- Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports.BMJ. 2018; 360: j5855
- Exposure to secondhand smoke and risk of cancer in never smokers: a meta-analysis of epidemiologic studies.Int J Environ Res Public Health. 2018; 15: 1981
- Gender-specific association between tobacco smoking and central obesity among 0.5 million Chinese people: the China Kadorie Biobank study.PLoS One. 2015; 10e0124586
- Association of childhood smoking and adult mortality: prospective study of 120 000 Cuban adults.Lancet Glob Health. 2020; 8: e850-e857
- The impact of cigarette smoking on life expectancy between 1980 and 2010: a global perspective.Tob Control. 2016; 25: 551-557
- The prevalence of chronic diseases and major disease risk factors at different ages among 150,000 men and women living Mexico City: cross-sectional analyses of a prospective study.BMC Public Health. 2009; 9: 9
- Association of smoking and smoking cessation with major causes of mortality in the Asia Pacific Region: the Asia Pacific Cohort Studies Collaboration.Tob Control. 2008; 18: 166-172
- Exposure to environmental tobacco smoke and risk of lung cancer in non-smoking women from Moscow, Russia.Int J Cancer. 1998; 75: 335-338
- Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.Lancet. 2017; 389: 1885-1906
- Social determinants of health and tobacco use in thirteen low and middle income countries: evidence from Global Adult Tobacco Survey.PLoS One. 2012; 7e33466
- Novel Foods and Food Allergens (NDA), Turck D, Castenmiller J, et al. Dietary reference values for sodium.EFSA J. 2019; 17e05778
- Diet, Nutrition, and the Prevention of Chronic Diseases.Report of a joint WHO/FAO Expert Consultation. World Health Organization, Geneva2003
- Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet.N Engl J Med. 2001; 344: 3-10
- Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.Lancet. 2018; 392: 496-506
- Urinary sodium and potassium excretion, mortality and cardiovascular events.N Engl J Med. 2014; 371: 612-623
- Association of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies.Lancet. 2016; 388: 465-475
- Fatal and nonfatal outcome, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion.JAMA. 2011; 305: 1777-1785
- Urinary sodium and potassium excretion and risk of cardiovascular events.JAMA. 2011; 306: 2229-2238
- Estimated urinary sodium excretion and risk of heart failure in men and women in the EPIC-Norfolk study.Eur J Heart Fail. 2014; 16: 394-402
- Association of urinary sodium and potassium excretion with blood pressure.N Engl J Med. 2014; 371: 601-611
- Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study.Lancet. 2017; 390: 2050-2062
See page 741 for disclosure information.
User LicenseCreative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy